GlassScriptPhysician profile
Christopher Duc Vuong
NPI 1750726774
$5,052.17
in general payments reported to CMS, 2019-2025
14 companies · $3,964 in 2025
The $3,964 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $176 · 2022: $170 · 2023: $449 · 2024: $293 · 2025: $3,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,798 · Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,797.67 |
| Food and Beverage | $1,908.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,949.50 | 2022-2025 | |
| Stryker Corporation | $1,703.22 | 2022-2025 | Scopis Ent |
| Genzyme Corporation | $511.31 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $296.99 | 2023-2025 | Dupixent |
| Smith+Nephew, INC. | $210.24 | 2020-2025 | Tula |
| Aimmune Therapeutics, INC. | $124.98 | 2024 | |
| Medtronic, INC. | $41.80 | 2025 | Propel |
| Optinose US, INC. | $40.86 | 2025 | |
| Inspire Medical Systems, INC. | $37.47 | 2025 | Inspire |
| Acclarent, INC | $37.28 | 2022-2023 | Trudi Nav Cable, Acclarent Aera |
| Glaxosmithkline, LLC. | $32.27 | 2022 | |
| Boston Scientific Corporation | $25.62 | 2025 | Wavewriter Alpha Prime 16 |
| Intersect Ent, INC. | $24.04 | 2022 | |
| Olympus America INC. | $16.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Vuong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.